Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Raw Materials (2023 - 2025)

Profound Medical has reported Raw Materials over the past 3 years, most recently at $3.0 million for Q4 2025.

  • Quarterly results put Raw Materials at $3.0 million for Q4 2025, up 50.61% from a year ago — trailing twelve months through Dec 2025 was $3.0 million (up 50.61% YoY), and the annual figure for FY2025 was $3.0 million, up 50.61%.
  • Raw Materials for Q4 2025 was $3.0 million at Profound Medical, up from $2.5 million in the prior quarter.
  • Over the last five years, Raw Materials for PROF hit a ceiling of $3.0 million in Q4 2025 and a floor of $2.0 million in Q4 2024.
  • Median Raw Materials over the past 3 years was $2.4 million (2023), compared with a mean of $2.4 million.
  • Biggest five-year swings in Raw Materials: fell 16.46% in 2024 and later surged 50.61% in 2025.
  • Profound Medical's Raw Materials stood at $2.4 million in 2023, then decreased by 16.46% to $2.0 million in 2024, then surged by 50.61% to $3.0 million in 2025.
  • The last three reported values for Raw Materials were $3.0 million (Q4 2025), $2.5 million (Q3 2025), and $2.7 million (Q2 2025) per Business Quant data.